Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Organics Limited was incorporated in 1989 and is based in Mumbai, India.
| Current Price | ₹118.65 |
|---|---|
| Market Cap | ₹158 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 14.6 |
| Return on Equity | 7.89% |
| 52-Week Range | ₹86.10 – ₹184.00 |
| Beta (1Y) | 0.51 |
| Dividend Yield | 2.67% |
1. Manufacturing and Trading of Bulk Drug and Intermediate-100%
Panchsheel Organics Ltd. is trading at ₹118.65, with a market capitalisation of ₹158 Cr.
Panchsheel Organics Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Panchsheel Organics Ltd. has a P/E of 14.6 and a return on equity of 7.89%.